Original Article Anti-oxidant pathways are stimulated by mesenchymal stromal cells in renal repair after ischemic injury

References

• Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 2003; 112:42–9.
   PubMed Web of Science ®Google Scholar
• Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, . Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischaemia–reperfusion injury in mice. J Am Soc Nephrol. 2003;14:1188–99.
   PubMed Web of Science ®Google Scholar
• Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004;14:1035–41.
   PubMed Web of Science ®Google Scholar
• Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, . Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004;15:1794–804.
   PubMed Web of Science ®Google Scholar
• Duffield JS, Bonventre JV. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int. 2005;68:1956–61.
   PubMed Web of Science ®Google Scholar
• Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289:F31–42.
   PubMed Web of Science ®Google Scholar
• Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, . Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006;17:2202–12.
   PubMed Web of Science ®Google Scholar
• Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, . Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005;68:1613–17.
   PubMed Web of Science ®Google Scholar
• Cavaglieri RC, Martini D, Sogayar MC, Noronha IL. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc. 2009;41:947–51.
   PubMed Web of Science ®Google Scholar
• Zhuo W, Liao L, Xu T, Wu W, Yang S. Mesenchymal stem cells ameliorate ischemia–reperfusion-induced renal dysfunction by improving the anti-oxidant balance of the ischemic kidney. Urol Int. 2011;86:191-6.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• McTaggart SJ, Atkinson K. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease. Nephrology (Carlton). 2007;12:44–52.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M. et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004;287:H2670–6.
   PubMed Web of Science ®Google Scholar
• Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, . Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007;72:430–41.
   PubMed Web of Science ®Google Scholar
• Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest. 2005;115:1756–64.
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, . Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008;2:84–291.
   Google Scholar
• Yew TL, Hung YT, Li HY, Chen HW, Chen LL, Tsai KS, . Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38MAPK activation. Cell Transplant. 2010 December 22. [Epub ahead of print]; PMID:21176394.
   Google Scholar
• Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, Ovize M. Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant. 2011;30:95–102.
   PubMedGoogle Scholar
• Kunter U, Rong S, Boor P, Eitner F, Muller-Newen G, Djuric Z, . Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol. 2007;18:1754–64.
   PubMed Web of Science ®Google Scholar
• Zarjou A, Kim J, Traylor AM, Sanders PW, Balla J, Agarwal A, Curtis LM. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am J Physiol Renal Physiol. 2011;300:F254–62.
   Google Scholar
• Brunswig-Spickenheier B, Boche J, Westenfelder C, Peimann F, Gruber AD, Kai Jaquet K, . Limited immune modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury. Stem Cells Dev. 2010;19:719–29.
   PubMed Web of Science ®Google Scholar
• di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol. 1999;277:F195–203.
   Google Scholar
• Cuttle L, Zhang XJ, Endre Z, Winterford C, Gobe GC. Bcl-X(L) translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress. Kidney Int. 2001;59:1779–88.
   PubMed Web of Science ®Google Scholar
• Gobe GC, Johnson DW. Distal tubular epithelial cells of the kidney: potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol. 2007;39:1551–61.
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Shen B, Chao L, Chao J. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther. 2008;19: 807–19.
   PubMed Web of Science ®Google Scholar
• Beyer Nardi N, da Silva Meirelles L. Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol. 2006;174:249–82.
   PubMedGoogle Scholar
• Montzka K, Führmann T, Müller-Ehmsen J, Wöltje M, Brook GA. Growth factor and cytokine expression of human mesenchymal stromal cells is not altered in an in vitro model of tissue damage. Cytotherapy. 2010;12:870–80.
   PubMed Web of Science ®Google Scholar
• Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, Endre ZH. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol. 2000;11:454–67.
   PubMed Web of Science ®Google Scholar
• Vesey DA, Cheung C, Pat B, Endre Z, Gobe GC, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant. 2004;19:348–55.
   PubMed Web of Science ®Google Scholar
• Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int. 2006;69:1806–13.
   PubMed Web of Science ®Google Scholar
• Hughes J, Gobe GC. Identification and quantification of apoptosis in the kidney using morphology, biochemical and molecular markers. Nephrology (Carlton). 2007;12:452–8.
   PubMed Web of Science ®Google Scholar
• Gobe GC. Identification of apoptosis in kidney tissue sections. Methods Mol Biol. 2009;466:175–92.
   PubMedGoogle Scholar
• Iatropoulos MJ, Williams GM. Proliferation markers. Exp Toxicol Pathol. 1996;48:175–81.
   PubMedGoogle Scholar
• Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, . Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838–43.
   PubMed Web of Science ®Google Scholar
• Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J. The indispensability of heme-oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol. 2000;156:1527–35.
   PubMed Web of Science ®Google Scholar
• Simon T, Anegon I, Blancou P. Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer. Immunotherapy. 2011;3(suppl 4):15–18.
   PubMedGoogle Scholar
• Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol. 2000;278:H643–51.
   PubMed Web of Science ®Google Scholar
• Vítek L, Jirsa M, Brodanová M, Kalab M, Marecek Z, Danzig V, . Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160:449–56.
   PubMed Web of Science ®Google Scholar
• Basile DP, Fredrich K, Alausa M, Vio CP, Liang M, Rieder MR, . Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol. 2005;288:F953–63.
   Google Scholar
• Miyata T, Takizawa S, van Ypersele de Strihou C. Hypoxia. I. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets. Am J Physiol Cell Physiol. 2011; 300:C226–31.
   PubMed Web of Science ®Google Scholar